Abstract, Oral & Poster Presentations

1. Gealt, M. A., Lindley, T.A., and Evans, J. L. (1982) Regulation of beta-amyrin biosynthesis in Aspergillus nidulans. J. Cell Biol. 95:46a. Presented at the 1982 Annual Meeting of the American Society of Cell Biologists, Baltimore, MD.

2. Evans, J. L. and Gealt, M. A. (1984) The insensitivity of ergosterol biosynthesis to cycloheximide in Aspergillus nidulans. Presented at the 1984 Annual Meeting of the American Society for Microbiology, St Louis, MO.

3. Evans, J.L., Moclock, M., and Gealt, M. A. (1985) The level of linolenic acid in Aspergillus nidulans varies as a  function of growth phase. Presented at the 1985 Annual Meeting of the American Society for Microbiology, Las Vegas, NV.

4. Evans, J. L. and Gealt, M. A. (1986) Effect of exgenous ergosterol on 3-hydroxy-3methylglutaryl-coenzyme A reductase of Aspergillus nidulans. Presented at the 1986 Annual Meeting of the American Society for Biological Chemists, Washington, DC.

5. Evans, J.L., Quistorff, and Witters, J.L. (1987) Zonation of hepatic lipogenic enzymes identified by dual digitonin pulse perfusion. Presented at the 1987 Gordon Research Conference on Lipid Metabolism, Meriden, NH.

6. Quistorff, B., Romert, P., Evans, J.L., and Witters, L.A. (1990) Digitonin perfusion in the study of metabolic zonation of the liver. Presented at the 1990 Alfred Benzon Symposium on Regulation of Hepatic Function, Copenhagen, Denmark.

7. Evans, J. L., Honer, C.M., Womelsdorf, B.E., and Bell, P.A. (1993) In vitro effects an insulin mimetic on glucose transport and metabolism, lipolysis, and protein phosphorylation. J. Cellular Biochem. 17A. Presented at the 1993 Keystone Symposium on Protein Phosphorylation and Dephosphorylation, Keystone, CO.

8. Bell, P.A., Deems, R.O., Evans, J.L., Honer, C.M., Young, D.A. (1994) Effects of WAG994 on lipid metabolism in vitro and in vivo. Presented at the 1994 Annual Meeting of the American Diabetes Association, New Orleans, LA.

9. Evans, J.L., Honer, C.M., Kaplan, E.L.,and Womelsdorf, B.E. (1994) Effects of wortmannin and lovastatin on insulin-stimulated phosphatidylinositol 3-kinase activity, glucose transport, anti-lipolysis and DNA synthesis. Presented at the 1994 Annual Meetng of the American Diabetes Asociation, New Orleans, LA.

10. Longhi, M.P., Fong, T.A.T., Chu, L., Jallal, B., Powell, T.J., Shawver, L.K., and Evans, J.L. (1996) The effect of the PTPase inhibitor, mpV(pic), on insulin receptor phosphorylation and glucose transport in vitro, and plasma glucose in db/db mice. Presented at the 1996 Northern California American Diabetes Association Research Symposium, San Francisco, CA.

11. Evans, J.L., Longhi, M.P., Chu, L., Fong, T.A.T., Jallal, B., Powell, T.J., and Shawver, L.K. (1997) The effects of the PTPase inhibitor, mpV(pic), on insulin receptor phosphoryation and glucose transport in vitro, and plasma glucose in db/db mice. Presented at the 1997 Keystone Symposium on Insulin Action and Secretion in NIDDM, Park, City, UT.

 12. Jallal, B., App, H., Longhi, M.P., Yuen, H., Zachwieja, J., Li, G., Kuchler, W.R., Sverbilov, A., Tang, C., McMahon, G., Shawver, L.K., Courtneidge, S.A., and Evans, J.L. (1997) A novel tyrosine phosphtase inhibitor enhances insulin action in vitro and lowers plasma glucose in orally-dosed db/db mice. Presented at the 1997 Annual Meetig of the American Diabetes Association, Boston, MA (Selected for presentation at President's Poster Session) 

13. Li, G., Sverbilov, A., Yuen, H., and Evans, J.L. (1998) Stimulation of glucose transport and PKB activation in 3T3-L1 adipocytes by the PTPase inhibitor, peroxovanadate, is wortmannin-insensitive. Presented at the 1998 Annual Meeting of the American Diabetes Association, Chicago, IL. 

14. Havel, P.J., Stanhope, K.L., Moreno-Aliaga, M.J., Kras, K.M., and Evans, J.L. (1999) Potential role for mitochondrial metabolism in regulating leptin production by cultured rat adipocytes. Presented at the 1999 Annual Meeting of the North American Asssociation for the Study of Obesity, Charleston, SC.

15. Byrd, E.A., Cesario, M.J., and Evans, J.L. (1999) Alpha-lipoic acid for diabetes and aging: the benefits of extending plasma half-life. Presented at the 1999 Annual Meeting of the American Academy of Anti-Aging Medicine, LAs Vegas, NE.

16. Youngren, J.F., Li, M., Manchem, V.P., Evans, J.L., Zhang, B.B., Maddux, B.A., and Goldfine, I.D. (2001) Small molecule insulin receptor activators potentiate insulin action in insulin resistant cells. Presented at the Seventh International Symposium on Insulin Receptors and Insulin Action, Geneva, Switzerland.

17. Manchem, V.P., Rao, S.S., Bajjalieh, S., Spevak, W.R., Shi, S., Cristobal, C.P., Toavs, D.K., Youngren, J.F., Pender, C., Evans, J.L., Goldfine, I.D., Lum, R.T., Schow, S.R., and Kozlowski, M.R. (2001) Characterization of a new orally acive insulin receptor tyrosine kinase activator with glucose lowering activity. Presented at the 2001 Annual Meeting of the American Diabetes Association, Philadelphia, PA.

18. Evans, J.L., Maddux, B.A., Lawrence, J.C., Jr., and Goldfine, I.D. (2001) Antioxidants protect against oxidative stress-induced insulin resistance in L6GLUT4 muscle cells. Presented at the 2001 Annual Meeting of the American Diabetes Association, Philadelphia, PA.

19. Balan, G., Abdelhameed, M.H., Dixon, R.M., Evans, J.L., and Chaouki, R. (2001) Pharmacokinetics of R-, S-, and total alpha-lipoic acid (LA) after administration of controlled and immediate release dosage forms of racemic-LA to healthy male volunteers. Presented at the 2002 Annual Meeting of the American Association of Pharmaceutical Scientists, Denver, CO.

20. Li, M., Youngren, J.F., Goldfine, I.D., Maddux, B.A., Dunaif, A., Zhang, B.B., and Evans, J.L. (2002) Decreased insulin receptor autophosphorylation in fibrobasts from patients with PCOS: effects of serine kinase inhibitors and insuln receptor activators. Presented at the 2002 Annual Meeting of the American Diabetes Association, San Francisco, CA.

21. Pender, C., Youngren, J.F., Manchem, V.P., Evans, J.L., Rao, S.S., Bajjalieh, S., Maddux, B.A., and Goldfine, I.D. (2002) Regulation of insulin receptor function by a small moecule insulin receptor activator. Presented at the 2002 Annual Meeting of the American Diabetes Association, San Francisco, CA.

22. Manchem, V.P., Cheng, M., Evans, J.L., Bajjalieh, S., Rao, S.S., Spevak, W.R., Cristobal, C.P., Lopez, J.L., Shi, S., Macsata, R.W., Gomez, R.F., Wick, M.M., Lum, R.T., Schow, S.R., and Keck, J.G. (2002) Novel insulin receptor activator compounds reverse HIV protease inhibitor-induced insulin resistance. Presented at the 2002 Annual Meeting of te American Diabetes Association, San Francisco, CA. 

23. Evans, J.L., Maddux, B.A., and Goldfine, I.D. (2005) The molecular basis for oxidative stress-induced insulin resistance. Presented at the 2005 Gordon Conference on Oxidative Stress and Disease, Ventura, CA.

24. Evans, J.L., Maddux, B.A., and Goldfine, I.D. (2005) The molecular basis of oxidative stress-induced insulin resistance. Presented at the 2005 FASEB Summer Conference on Glucose Transporter Biology, Snowmass, CO.